WeiPing Lu (Weiping Lu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Glycemic Control

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Yao Wang, Chengxia Jiang, Xiaolin Dong, Mingwei Chen, Qin Gu, Lihui Zhang, Yanqin Fu, Tianrong Pan, Yan Bi, Weihong Song, Jing Xu, WeiPing Lu, Xiaodong Sun, Zi Ye, Danli Zhang, Liang Peng, Xiang Lin, Wei Dai, Quanren Wang, Wenying Yang
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Yao Wang, Chengxia Jiang, Xiaolin Dong, Mingwei Chen, Qin Gu, Lihui Zhang, Yanqin Fu, Tianrong Pan, Yan Bi, Weihong Song, Jing Xu, WeiPing Lu, Xiaodong Sun, Zi Ye, Danli Zhang, Liang Peng, Xiang Lin, Wei Dai, Quanren Wang, Wenying Yang
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial. Diabetes, obesity & metabolism (2024)
Yao Wang, Chengxia Jiang, Xiaolin Dong, Mingwei Chen, Qin Gu, Lihui Zhang, Yanqin Fu, Tianrong Pan, Yan Bi, Weihong Song, Jing Xu, WeiPing Lu, Xiaodong Sun, Zi Ye, Danli Zhang, Liang Peng, Xiang Lin, Wei Dai, Quanren Wang, Wenying Yang
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Yijun Li, Zhifeng Cheng, WeiPing Lu, Ping Li, Hongwei Jiang, Jing Yang, Jing Xu, Cheng Zhang, Lili Zhang, Yao Wang, Fang Bian, Weiying Guo, Xuefeng Yu, Xiaopan Chen, Dong Zhao, Bo Feng, Shen Qu, Jie Qin, Yifei Zhang, Lin Wang, Hong Cheng, Yi-Ming Mu
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes, obesity & metabolism 26 (3) (2023)
Yijun Li, Zhifeng Cheng, WeiPing Lu, Ping Li, Hongwei Jiang, Jing Yang, Jing Xu, Cheng Zhang, Lili Zhang, Yao Wang, Fang Bian, Weiying Guo, Xuefeng Yu, Xiaopan Chen, Dong Zhao, Bo Feng, Shen Qu, Jie Qin, Yifei Zhang, Lin Wang, Hong Cheng, Yi-Ming Mu
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes, obesity & metabolism 26 (3) (2023)
Yijun Li, Zhifeng Cheng, WeiPing Lu, Ping Li, Hongwei Jiang, Jing Yang, Jing Xu, Cheng Zhang, Lili Zhang, Yao Wang, Fang Bian, Weiying Guo, Xuefeng Yu, Xiaopan Chen, Dong Zhao, Bo Feng, Shen Qu, Jie Qin, Yifei Zhang, Lin Wang, Hong Cheng, Yi-Ming Mu
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes, obesity & metabolism (2023)
Juming Lu, Liujun Fu, Yan Li, Jianlin Geng, Li Qin, Ping Li, Hailong Zheng, Zilin Sun, Yan Bing Li, Lihui Zhang, Yadong Sun, Daoxiong Chen, Gui-Jun Qin, WeiPing Lu, Yushan Guo, Yuwei Zhang, Haiyan Liu, Tao Zhang, Jianjun Zou
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism 23 (5) (2021)